MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

July 12, 2019

Primary Outcome Measures

Objective response rate (ORR) [ Time Frame: 3 months-2 years ]Percentage of subjects with complete or partial response

Secondary Outcome Measures

  1. duration of response (DUR) [ Time Frame: up to 2 years ]measured from first observation of response to disease progression
  2. progression free survival (PFS) [ Time Frame: up to 2 years ]measured from start of study to date of progression or death

Other Outcome Measures

  1. Incidence of adverse events [ Time Frame: up to 2 years ]description of adverse events by frequency, severity and causality
  2. change from baseline in liver transaminases, ALT and AST [ Time Frame: up to 2 years ]changes in liver transaminases from prior to first study drug treatment to various timepoints throughout the treatment and follow-up period

Inclusion Criteria

  • Histologically confirmed locally advanced or metastatic pleural mesothelioma
  • Failed one prior treatment regimen including cisplatin-based chemotherapy
  • Eastern cooperative oncology group (ECOG) performance status; 0,1
  • Adequate organ function
  • Measurable disease per RECIST

Exclusion Criteria

  • Candidate for surgical resection
  • has active autoimmune disease, primary or acquired immunodeficiency
  • significant cardiovascular disease
  • has active interstitial lung disease
  • has active infection or HIV, hepatitis B or C
  • previous anti-PD-1, PD-L1 or CTLA-4 inhibitor immunotherapy
  • other clinical significant disorder that could affect conduct of study
CONTACT INFORMATION

Name*
Address*
Have you received a diagnosis?*
DIAGNOSIS
MM slash DD slash YYYY
This field is for validation purposes and should be left unchanged.

Quick Facts

Accepts Healthy Volunteers
Ages Available for Study
ClinicalTrials.gov Identifier
Collaborators
Contacts(s)
Location(s)
Estimated Enrollment
Estimated Study Start Date
Estimated Primary Completion Dates
Full Title
Genders Eligible for Study
Investigator(s)
Last Updated
Other Contact